Active, Not Recruiting Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) NCT04268706 Conditions Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Disease Recurrent, +10 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States University of Chicago Medical Center — Chicago, Illinois, United States Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States Sarah Cannon Research Institute — Nashville, Tennessee, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy NCT05352828 Conditions Classical Hodgkin Lymphoma, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Locations City of Hope National Medical Center — Duarte, California, United States University of Miami — Miami, Florida, United States UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States Baylor College of Medicine — Houston, Texas, United States View more locations Show fewer locations Loading locations... View Trial Details
